Physician profile
Mitchell Engler
NPI 1326061755
$1,987.32
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,245 · 2020: $511 · 2021: $175 · 2022: $43.83 · 2023: $13.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $215.92 | 2019-2021 | |
| Amgen INC. | $187.03 | 2019-2021 | |
| Novo Nordisk INC | $151.18 | 2019-2021 | |
| Glaxosmithkline, LLC. | $140.07 | 2019-2023 | Trelegy Ellipta |
| Merck Sharp & Dohme LLC | $139.57 | 2019-2021 | |
| Philips North America LLC | $136.56 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $126.19 | 2019-2020 | |
| Shire North American Group INC | $108.66 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $97.50 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $77.19 | 2019-2021 | |
| Genentech USA, INC. | $68.06 | 2019 | |
| Harmony Biosciences LLC | $57.00 | 2020 | |
| Mylan Specialty L.P. | $42.90 | 2019-2020 | |
| Grifols USA, LLC | $41.80 | 2019-2021 | |
| Amarin Pharma, INC. | $41.56 | 2019-2021 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $40.23 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $35.90 | 2019 | |
| Insmed, INC. | $29.98 | 2020 | |
| Mannkind Corporation | $29.68 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $29.39 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $27.87 | 2020 | |
| Circassia INC. | $24.56 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.49 | 2019 | |
| Jazz Pharmaceuticals INC. | $22.77 | 2019-2020 | |
| Medtronic Minimed, INC. | $22.50 | 2019 | |
| Genzyme Corporation | $14.93 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $14.61 | 2020 | |
| Valeritas, INC. | $13.97 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $13.76 | 2019 | |
| Sanofi-Aventis U.S. LLC | $12.49 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Engler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.